Monitoring of Immunity Markers in Intensive Care Patients and Link with Recurrence and Relapse of Ventilator-associated Pneumonia

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this observational study is to show the direct correlation between the occurrence of recurrence of VAP and postagressive immunoparalysis, monitored by HLA-DR rate below litterature-acknowledged threshold, in a well conducted antibiotherapy context, in patient admitted in the Intensive Care Unit. The main questions it aims to answer are: * evaluation of the association between death and persistence of immunoplegia using HLA-DR monitoring * search an association between immunoplegia depth and severity of the initial state of shock * search an association between immunoplegia depth and viral reactivation * compare association of immunoplegia duration and HLA-DR nadir and VAP occurrence Blood samples will be taken from participants to HLA-DR dosage, at the time of inclusion and once a week then.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient over 18 years old

• Patient admitted in the Intensive Care Unit of the CHIAP

• Patient under mechanical ventilation

• Patient with infectious pneumonia

• Informed Consent Form (ICF) obtained from the patient or emergency ICF obtained from close relatives

• Patient beneficiary of French social security, whatever the regime

Locations
Other Locations
France
Centre Hospitalier Intercommunal Aix-Pertuis
RECRUITING
Aix-en-provence
Contact Information
Primary
Laurent LEFEBVRE, MD
llefebvre@ch-aix.fr
0442335650
Time Frame
Start Date: 2023-10-04
Estimated Completion Date: 2025-09
Participants
Target number of participants: 40
Treatments
Interventional - blood collection
HLA-DR dosage, at the time of inclusion and once a week then
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Intercommunal Aix-Pertuis

This content was sourced from clinicaltrials.gov